By proceeding, you agree to our Terms of Use and Privacy Policy.
With the ever-increasing competitive nature of the ADC field, target selection is a key differentiator between having a failed or successful ADC. Being able to optimally triangulate the choice of linker-payload, target and indication is vital in developing an ADC that can have the biggest impact on patients.
Witness roundtable discussions, sessions on biology and drug discovery.
Learn about how to think about the payload and target holistically, understand expression profiles, how to quantify cell surface protein dynamics.
Join 80+ peers for invaluable scientific and strategic discussions to ensure you are matching your goal and linker-payload technologies to maximize patient outcomes.
Listen to target ID/validation, cancer biology and drug discovery experts from across the biopharma industry provide an A-Z coverage of the key considerations.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US.
Celebrating it’s 20 th year in business, Precision Antibody has found itself in the forefront of the Custom Antibody industry.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.